Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zoetis Inc. (ZTS)

Core Viewpoint - The law firm Kirby McInerney LLP is investigating potential claims against Zoetis Inc. regarding possible violations of federal securities laws and unlawful business practices [1] Group 1: Investigation Details - The investigation is focused on whether Zoetis and/or its officers have engaged in unlawful practices [1] - The investigation follows a report from Investor's Business Daily that alleged Zoetis' arthritis shots, Librela and Solensia, caused health issues in pets [1] Group 2: Market Reaction - Following the Wall Street Journal report, Zoetis' stock price fell by $12.75, approximately 7.84%, from $162.73 on April 11, 2024, to $149.98 on April 12, 2024 [1]